Menu
Non-scarring. Incision-free. Thyroid preserving
STARmed Thyroid Radiofrequency Ablation for thyroid nodules is a minimally invasive procedure. Our RFA solutions have been helping patients for over two decades. We are proud to have created and developed the first thyroid-specific radiofrequency equipment in the world.
All devices are clinically proven and FDA-cleared. For non-functioning benign thyroid nodules, clinical studies have shown 80% volume reduction rate (VRR) at 12 months follow-up, and 95% VRR 60 months after the RFA procedure1,2
Thyroid Radiofrequency Ablation (RFA) was first introduced in 2002 in Seoul, South Korea. Today, there are over 150+ clinical articles worldwide demonstrating the efficacy of this treatment.
STARmed is the only company that has a complete solution for Thyroid RFA for every patient. Our electrodes come in a range of sizes to address all clinical issues related to the thyroid. That’s why we’re leading the world with our cutting-edge thyroid RFA technology.
Americans have some form of thyroid disease, with the vast majority identified as benign lesions.
thyroid operations are performed each year in the United States.
thyroid resections are performed for benign diseases where patients could benefit from a less invasive option.
The Continuance Mode of the VIVA combo RF Generator produces radiofrequency (RF) output constantly throughout the procedure. Simultaneously, it automatically adjusts the amount of energy applied to the targeted nodule according to real-time impedance feedback. This innovative mechanism ensures the procedure’s safety by minimizing undesired tissue over-ablation.
The monopolar star RF Electrode stands out as the first thyroid-dedicated RF electrode in the market. It is uniquely designed with a shorter shaft lengths of 7 or 10 cm. This shorter length is designed to accommodate the gland’s superficial location.
It also has a thinner shaft of 18 or 19 gauge for enhanced energy control. It comes with an array of active tip lengths at 4mm, 5mm, 7mm, and 10mm to cater to different nodule sizes.
The monopolar VIVA II RF Electrode is the latest innovation in RF ablation. The VIVA Adjustable RF Electrodes are the first of their kind in the world. The VIVA II features an adjustable active tip ranging from 5mm to 30mm. Thus, it can accommodate multiple large nodules of varying sizes with one electrode in one session.
Its latest sharp technology ensures a smooth puncture, while the smaller handle allows for greater precision control. It’s a versatile RFA tool with clinically proven results.
The Continuance Mode and the unique design of the STARmed RF Electrodes enable the Moving-Shot technique. This promotes ablation in units to limit thermal damage to surrounding tissue.
Before STARmed
Thyroid RFA
6 months after
STARmed Thyroid RFA
Individual results may vary.
Photo courtesy of Dr. Jung Hwan Baek
STARmed America is committed to refining the customer learning journey. We provide structured and measured procedure training programs for physicians and your care team. Trainings are ongoing and take place in major cities across the country. Commit to improving your practice this year.
The VIVA combo RF System is FDA-cleared. It is intended for use in percutaneous and intraoperative coagulation and ablation of tissue.
